The plant is actively expanding its portfolio and introducing new production facilities. Bilateral cooperation between government and business will continue in the future.
Russia should minimize its dependence on imports of ready-made medicines and pharmaceutical substances, Russian Deputy Prime Minister Tatyana Golikova said on Thursday. /TASS/
"In 2020,...
It is envisaged to implement the project in three stages from 2021 to 2024, the amount of investment from the company "SOLYPHAR" will be more than 20 million US dollars, in accordance to the international GMP standards.